Tag: disease

0 0 0 Comment
Posted in HEADLINES

Bluebird bio’s stock plunges after submission delay of sickle cell disease treatment

Shares of Bluebird bio Inc. BLUE, -14.77% traded 15.1% into the red in morning trading Thursday, after the gene therapy…

Gavel
0 85 0 Comment
Posted in FINANCE Stock Market

Swedish kidney disease biotech Calliditas Therapeutics files for a $75 million US IPO

Calliditas Therapeutics, a Swedish biotech developing novel therapies for inflammatory kidney disease, filed on Thursday with the SEC to raise…